Skip to main content
Clinical Trials/ACTRN12617001374358
ACTRN12617001374358
Recruiting
Not Applicable

Development and validation of a novel, wearable continuous ECG monitor for automated detection of atrial fibrillation in patients attending a hypertension outpatient clinic.

Alerte Digital Health0 sites50 target enrollmentSeptember 27, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Alerte Digital Health
Enrollment
50
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2017
End Date
TBD
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Alerte Digital Health

Eligibility Criteria

Inclusion Criteria

  • Age over 18 and less than 80 years.
  • Ability to give informed consent in English without the need for a translator.
  • Attendance at the Royal Perth Hospital hypertension clinic.
  • Presence of sinus rhythm or atrial fibrillation.
  • Willingness to return devices to Royal Perth Hospital hypertension clinic.

Exclusion Criteria

  • Permanent pacemaker or defibrillator.
  • Presence of arrhythmias other than atrial fibrillation on baseline ECG. (Presence of ventricular ectopy is not an exclusion criteria).
  • Dementia or severe physical dependence.
  • Inability to attend on two consecutive days to allow for return of the monitoring system, or other social circumstances in which an ECG system and smart phone may not be practical.

Outcomes

Primary Outcomes

Not specified

Similar Trials